Children's Hospital of Philadelphia
Part of University of Pennsylvania (Wikidata)
CompanyUnited StatesFounded 1855RORWikidata
Children's Hospital of Philadelphia develops one asset, in phase 2 (MIB-626 in Alzheimer's disease). Mostly small molecule acting on oxidative phosphorylation, Mitochondrial biogenesis (PGC-1α) and sirtuin signalling; based in the United States, founded in 1855.
- Assets
- 1
- Furthest
- Phase 2
- Trials
- 18
- Signals
- 0
Pipeline
1Oral beta-nicotinamide mononucleotide NAD+ precursor enhancing NAD+ biosynthesis and mitochondrial function.
Phase 2Small moleculeOxidative phosphorylationMitochondrial biogenesis (PGC-1α)Alzheimer's diseaseCovid19Partner
Full company profiles: pipeline, trials, funding and people.
See Pro- Evidence behind the mechanisms6
- Trials34
- Signals2
- Integrity notices3
- Similar companies6
Updated 8 Oct 2026 · 40 sources